Mutations in the transcription factor gene SOX18 cause vascular, lymphatic and hair follicle defects in humans with dominant and recessive forms of hypotrichosis-lymphedema-telangiectasia (HLT) syndrome. Here, we clarify the role of SOX18 in the vascular dysfunction in HLT by ultrastructural, immunofluorescence, molecular and functional analysis of vascular anomalies in embryos of the naturally occurring Sox18-mutant mouse strain ragged-opossum (Ra Op ). Early genesis and patterning of vasculature was unimpaired in Ra Op embryos, but surface capillaries became enlarged from 12.5 dpc and embryos developed massive surface hemorrhage by 14.5 dpc. Large focal breaches in the endothelial barrier were observed, in addition to endothelial hyperplasia associated with impaired pericyte recruitment to the microvasculature. Expression of the genes encoding the endothelial factors MMP7, IL7R and N-cadherin was reduced in Ra Op embryos, suggesting that these are downstream targets of SOX18. Together, our results indicate that vascular anomalies in HLT arise from defects in regulation of genes required for the acquisition of structural integrity during microvascular maturation.
INTRODUCTION
Disorders in blood vessel development and function are a feature of a large number of human genetic diseases, and can arise at any one of a complex series of steps. During vasculogenesis, angioblasts originate in the blood islands of the yolk sac and either differentiate in situ to form the yolk sac vasculature or migrate to sites in the embryo proper to form the primary vascular plexus: the dorsal aortae, cardinal veins and endocardial tubes (1) . During angiogenesis, this plexus is remodeled and extended through endothelial proliferation, migration and association to form a vascular network throughout the embryo (2). Maturation of these vessels then involves the formation of a basal lamina and the recruitment of pericytes, and interaction among and between endothelial cells and pericytes to optimize vascular structure and function (3) , but a comprehensive picture of the regulatory networks involved in the progression of vessels into and through the maturation phase is lacking.
A growing number of studies have indicated a role for the transcription factor SOX18 in vascular development. A member of the SRY-related HMG box (SOX) family of transcription factors, SOX18 is characterized by a HMG-type DNA-binding domain and a C-terminal transcriptional transactivation domain (4, 5) . Sox18 is transiently expressed in endothelial cells of all developing blood vessels, whether formed by vasculogenesis or angiogenesis, in embryos of mice, chickens and fish (6 -11) . Expression is reactivated during adult neovascularization associated with wound healing and tumorigenesis (12, 13) .
Mutations of SOX18 are responsible for the human syndrome hypotrichosis-lymphedema-telangiectasia (HLT), indicating an involvement of SOX18 in the development or function of blood vessels, the lymphatic system and hair follicles (14) . Vascular dysfunction in HLT is characterized by cutaneous telangiectasias and other abnormal dilations of superficial vasculature. HLT has been attributed to recessive missense mutation of the SOX18 HMG box region and, in one case, dominant nonsense mutation that interrupts the trans-activation domain and removes the native C-terminus of the SOX18 protein. Sox18 mutations also underlie the ragged series of spontaneous mouse mutants, named for their characteristic sparse fur. The four alleles-ragged (Ra), ragged-Jackson (RaJ), ragged-like (Ragl) and raggedopossum (Ra Op )-all carry single base deletions in Sox18 associated with the trans-activation domain-encoding region, mirroring the dominant mutation observed in HLT. These mutations result in dominant-negative loss-of-function of SOX18 (9, 12, 13, 15, 16) . All four ragged mutants show a similar phenotypic spectrum to human HLT patients (14,17 -23) .
Ragged mice offer a powerful system to address the role of Sox18 in vascular development and function, and a tractable model for studies of the etiology of vascular defects in HLT. However, because of a number of factors including inability to identify mutants by molecular genotyping, only limited phenotypic analyses were possible after the initial discovery of ragged alleles in the 1950s and 1960s. Investigations of the Ra allelic mutant revealed dilation and rupture of peripheral vasculature (20) . The most severe allele, Ra Op , was found to cause edema in some putative heterozygous embryos after 11 dpc (days post coitum) and death in putative homozygotes before 11 dpc (19) . A significant number of heterozygous Ra Op neonates were also reported to show edema, cyanosis, chylous ascites and small regions of superficial epidermal hemorrhage (18) . However, because the blood vessels of these ragged mutants were not characterized during this early research, the role of Sox18 in establishing a functional vascular system in mice has not been established.
In this study, we examine the development of blood vasculature in Ra Op mouse embryos. We demonstrate abnormal microvascular enlargement in homozygous mutant embryos from 12.5 dpc, followed by focal rupture of the microvasculature with increasing severity, culminating in gross hemorrhage, edema and death around 14.5 dpc. Using histological, molecular and ultrastructural analysis of the Ra Op endothelium, we show that these defects are owing to focal lesions in the endothelium and endothelial hyperplasia associated with impaired pericyte recruitment, and identify a number of potential target genes involved in blood vessel maturation. These findings indicate a critical role for SOX18 in the maturation rather than the early modeling of the blood vasculature, explaining the telangiectasia associated with HLT syndrome. /þ matings were represented at close to the expected Mendelian ratio of 25% at 8.5, 9.5, 10.5, 12.5, 13.5 and 14.5 dpc (Fig. 1A) . A reduced proportion of homozygotes (10%; n ¼ 30) was observed at 11.5 dpc, but this reduction is unlikely to be significant because it was not sustained at later stages. No homozygous mutant embryos survived beyond 14.5 dpc. Clearly, mutant embryos survive the critical period for establishment of a functional cardiovascular system. Ra Op homozygous embryos at 8.5-10.5 dpc (n ¼ 15) showed no gross phenotypic differences from wild-type siblings (Fig. 1B) . This period represents a key window for the appearance of primary defects in cardiovascular development (24, 25) . In situ hybridization of Ra Op homozygotes at 10.5 dpc, using a probe for the vascular endothelial marker Flk-1 (26), confirmed the presence of an extensive surface vascular network with overtly normal vessel density and branching (n ¼ 3; Fig. 1B ). Moreover, histological examination at 11.5 dpc showed normal development of the cardinal veins, dorsal aortae and cranial vessels (Fig. 1C ). These observations suggest that differentiation, proliferation, migration and association of endothelial cells, and patterning and establishment of the primary vascular plexus are unaffected by Sox18 dysfunction.
RESULTS

In
Development of gross vascular anomalies in Ra
Op mutant embryos
Phenotypic differences between Ra
Op and wild-type embryos appeared from 12.5 dpc onward. At 12.5 dpc, surface microvasculature in the trunk, head, proximal limb and neck, in most cases, appeared enlarged when compared with wild-type embryos (67%, n ¼ 9; Fig. 2 ). Many mutants (63%, n ¼ 11) also showed severe subcutaneous edema in the trunk and neck regions ( Fig. 2A) .
Vascular defects became increasingly severe in mutant embryos with age. At 13.5 dpc, all mutant embryos showed enlarged surface microvasculature, multiple regions of vascular hemorrhage and generalized edema (n ¼ 5; Fig. 2 ). By 14.5 dpc, large-scale vascular hemorrhage was seen in all mutant embryos, and hematoma was visible over large areas of the trunk, neck and head, together with persistent enlarged surface microvessels, particularly around the anterior cranial region (n ¼ 8; Fig. 2 ). Enlarged capillaries also frequently appeared ruptured. By this stage, edema had mostly dissipated with the degradation of epidermal tissue, and blood circulation in the yolk sac vasculature of these embryos had ceased.
These observations indicate that Sox18 mutation results in severe vascular dysfunction during mouse embryo development, and that these defects arise later in development than previously suggested (18, 19) . In addition, most Ra Op embryos develop edema, which may be owing to either cardiovascular or lymphatic defects, or both. We have analyzed the development of the lymphatic system in Sox18 mutant mice in
2840
Human Molecular Genetics, 2009, Vol. 18, No. 15 a separate study (27) , and focus here on a detailed characterization of blood vascular development in Ra Op homozygous mutants.
Vascular enlargement and hemorrhage in Ra
Op embryos
To gain a clearer understanding of the role of Sox18 in blood vessel development, we examined the histology of Ra Op mutant embryos. At 12.5 and 13.5 dpc, subdermal microvasculature was enlarged in Ra Op homozygotes (n ¼ 7; Fig. 3A , black arrowheads). On an average, microvessel diameter was 21% higher in mutant embryos than in wild-type embryos at 12.5 dpc (P , 0.005), and at 13.5 dpc, this difference was 35% (P , 0.005). Analysis of the distribution of vessel diameters showed an increasing trend towards larger microvessel sizes in the mutant. At 12.5 dpc, there was an increased frequency of very large microvessels (.15 mm) in mutants and by 13.5 dpc, vascular enlargement caused an increase in the frequency of all microvessels greater than 10 mm (Fig. 3B) .
Vascular enlargement in Ra Op homozygotes appeared to be specific to microvasculature. Enlargement of jugular veins was observed between 12.5 and 13.5 dpc in some Ra
Op homozygotes but was associated with the dysgenesis of associated lymph sacs (Fig. 3A , black arrowheads). Minor variations in the size of thoracic vessels were observed in all embryos between 12.5 and 13.5 dpc, but most Ra Op homozygous vessels were comparable to wild-type (Fig. 3A) .
From 13.5 dpc, the Ra Op subdermal microvasculature also showed evidence of vascular rupture and hemorrhage (n ¼ 5; Fig. 3A, red arrowheads) . By 14.5 dpc, hemorrhage was observed throughout the subdermal mesenchyme in all embryos examined (n ¼ 3; Fig. 3A, red arrowheads) . The extent of microvascular rupture in Ra Op homozygotes at 14.5 dpc (see below) was so high that it precluded the accurate measurement of vessel diameter in the subdermal tissue at this stage.
In summary, qualitative and quantitative histological analysis showed microvascular enlargement correlating with hemorrhage, from 12.5 dpc, in Ra Op mutant embryos. These findings point to primary defects in blood vessel maturation and integrity in these mutants.
Loss of vascular integrity is due to endothelial rupture
We next examined the development of cytostructural components of the maturing microvasculature required for vascular integrity. Due to the effects of edematous swelling on the tissue architecture of the trunk region, only subdermal tissue from the tail region could be examined at this level. The structure of blood microvessels from wild-type and mutant embryos was compared at 12.5 and 13.5 dpc by transmission electron microscopy. Small capillary walls showed comparable morphology of endothelial cells, endothelial tight junctions and basal laminae in mutants and wild-type tissue (Fig. 4A) . However, ruptures of the endothelial barrier were observed in some larger microvessels in the mutant embryos. These ruptures were found across inter-endothelial junctions (Fig. 4B, upper, arrowheads) and also through the endothelial cell membranes (Fig. 4B, lower, arrowheads) , indicating that rupture was not necessarily due to the failure of junctional components in mutant vessels.
We performed a series of dye injection experiments to functionally determine the pattern, frequency and severity of the vascular ruptures (Fig. 5) . Examination of the surface microvasculature of India ink-perfused embryos at 12.5 -13.0 dpc showed small focal regions of ink extravasation in one embryo (n ¼ 3; Fig. 5B ). By 13.5 dpc, larger focal regions of extravasation were visible in the epidermal microvasculature of the trunk and head of all mutant embryos examined (n ¼ 4; Fig. 5A and B) . In histological sections of some 
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injected embryos, the pattern of ink extravasation correlated to evidence of hemorrhage, marking vascular breaches large enough to accommodate 6 mm erythrocytes. However, examples of ink extravasation in areas of no hemorrhage were also observed (Fig. 5C ), indicating the presence of smaller vascular lesions between 50 nm and 5 mm in size.
The presence of these smaller vascular breaches indicated that loss of vascular integrity was more widespread in mutant embryos than was indicated by evidence of hemorrhage and thus that loss of vascular integrity may be more severe at earlier stages (12.5 dpc), when edema was observed in the presence of little or no hemorrhage in mutant embryos. . Enlargement of cephalic major vessels (third row, black arrowheads, JV, scale bars, 100 mm) was also observed in some Ra Op /Ra Op embryos and was associated with the dysgenesis of associated lymph sacs. The thoracic major vessels (fourth row, TA, scale bars, 25 mm) of Ra Op /Ra Op embryos predominantly did not appear enlarged (12.5-13.5 dpc). (B) Quantitation of lumen diameter in subdermal vessels at 12.5 and 13.5 dpc. Note that the overall shift towards larger vessels, particularly at 13.5 dpc. n ¼ 3 -4 for each time point and genotype; ÃÃ P , 0.005. CA, carotid artery; JV, jugular vein; IJV, internal jugular vein; EJV, external jugular vein; LS, lymph sac; TA, thoracic aorta; CV, cardinal vein.
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Endothelial hyperplasia associated with defects in pericyte recruitment
In addition to vascular hemorrhage, Ra Op embryos showed evidence of microvascular enlargement at the gross level and in histological sections of the trunk (Fig. 3A) . To investigate the cause of this enlargement, we counted the number of endothelial cells per vessel cross-section in 12.5 and 13.5 dpc subdermal vasculature after hematoxylin -eosin staining, and immunofluorescence staining of 13.5 dpc embryo sections using an antibody directed against the endothelial marker, PECAM-1 (Fig. 6A) . Quantitation of endothelial cell nuclei in Ra Op confirmed a higher number of endothelial cells (229/95 vessels) than in wild-type (180/95 vessels; Fig. 6A ). Normalization of the number of endothelial cells by vessel diameter showed a significantly greater value at 12.5 dpc in Ra Op animals and no difference at 13.5 dpc (data not shown). Therefore, vessel enlargement appeared to be owing to endothelial hyperplasia rather than distension of endothelial cells.
Study of other vessel maturation mutants has shown a correlation between endothelial hyperplasia in the microvasculature and inadequate recruitment of pericytes to the maturing blood microvessels (28) . We therefore tested whether this was true of Ra Op mutants by immunofluorescence analysis of subdermal microvessels for NG2 proteoglycan, a pericyte marker. Pericytic investment of microvasculature was quantified by counting the proportion of subdermal vessels in immunofluorescence sections which were associated with NG2-stained Fig. S1 ). However, quantitation of sectioned microvessels in the trunk region showed that significantly fewer microvessels (9.3%) were associated with NG2-positive pericytes in Ra Op at 13.5 dpc compared with wild-type (17.8%; Fig. 6B ). This result indicates an impairment of pericyte recruitment to subdermal blood microvessels in Ra Op mutant embryos, likely contributing to both endothelial hyperplasia and reduced structural integrity of these vessels.
Molecular analysis of vascular defects in Ra
To explore the molecular basis of the endothelial defects in Ra Op embryos, we assayed expression levels of genes encoding several key proteins required for vascular structure and function. These included occludin, tyrosine kinase with immunoglobulin and epidermal growth factor homology domains-1 (Tie1), zonula occludens-1 (ZO-1), platelet-derived growth factor-B (Pdgfb), matrix metalloprotease-7 (Mmp7), interleukin-7 receptor (Il7r) and N-cadherin.
Quantitative real-time RT-polymerase chain reaction analysis was performed using 10.5 dpc tissue from the trunk region of Ra Op homozygous and wild-type siblings. No significant difference in the transcript levels of occludin, Tie1, ZO-1 or Pdgfb was observed at this stage (Fig. 7) . However, Il7r, Mmp7 and N-cadherin were downregulated in Ra Op homozygotes by 2.2-, 4.1-and 12-fold, respectively (Fig. 7) . Thus, Il7r, Mmp7 and N-cadherin were identified as candidate downstream targets of SOX18 regulation.
DISCUSSION
Mutations in SOX18 in patients with HLT indicate a role for SOX18 in the development or function of the blood vasculature. We show here that loss of SOX18 function in mice causes defects in blood vessel maturation of microvasculature resulting in vessel enlargement and hemorrhage from 12.5 dpc, rather than defects in the initial differentiation and organization of the primary vascular plexus. Our findings illuminate the etiology of the telangiectasia associated with HLT, and suggest that SOX18 acts as a transcriptional activator of genes required for vascular structural integrity and the recruitment of pericytes to developing blood vessels.
Early versus late roles for SOX18 during vascular development
Previous studies suggested a role for SOX18 in the early specification of endothelial cells during vasculogenesis and/or the migration and proliferation of endothelial cells during angiogenesis. Sox18 is expressed during endothelial cell differentiation in mouse, chicken and zebrafish (6, 10, 29) . A role for SOX18 and SOX7 in arteriovenous specification is reported in zebrafish (7, 29, 30) . Over-expression of SOX18 in HUVEC endothelial cells promoted tube formation in vitro, whereas expression of dominant-negative Ra Op SOX18 resulted in short tubes that failed to associate into a network (13) . Expression of Ra Op SOX18 in cell culture also impaired cell migration by disruption of the actin cytoskeleton, and impeded proliferation through changes in cell cycle regulation (13) . Finally, in vitro assays of tube formation using liver endothelial cells of Sox18 2/2 /Sox17 2/þ mice demonstrated a reduction in branch number and vessel length during the remodeling of the primary tubes formed (31) .
Our present data indicate a role for SOX18 in establishing and maintaining the structural integrity of the developing blood vessels during vessel maturation. The endothelial hyper- Op /Ra Op embryos shows endothelial hyperplasia and defects in pericyte recruitment. (A) Endothelial cells per vessel lumen cross-section were quantified on 12.5 and 13.5 dpc hematoxylin-eosin-stained sections. Quantification was validated by immunofluorescence using the endothelial marker PECAM-1 (green) and DAPI (blue, n) at 13.5 dpc. (B) Immunofluorescence detection of PECAM-1 (green) and the pericyte-specific marker NG2 (red). Major vasculature (thoracic aorta) showed little difference in pericyte investment in 13.5 dpc mutant embryos (left panel). By contrast, the Ra Op / Ra Op subdermal microvasculature showed fewer vessels associated with pericytes when compared with wild-type at 13.5 dpc (right panel, white arrowheads). Ã P , 0.05; TA, thoracic aorta; Scale bars: (A) 10 mm; (B) left panel, 50 mm; right panel: 20 mm.
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Human Molecular Genetics, 2009, Vol. 18, No. 15 plasia, focal membrane rupture and reduced ability to recruit pericytes in Ra Op embryos are likely to be related phenomena, since pericytes stabilize vessel structure and induce endothelial quiescence (28, 32, 33) . The time of death of Ra Op embryos, around 14.5 dpc, is similar to that of mutant mouse models of several factors involved in vessel maturation (34 -38) .
Available evidence therefore suggests that SOX18 acts at multiple points in the pathway of blood vessel development. If this is the case, any early phenotypes resulting from loss of SOX18 function must be masked in Ra Op mice. This phenomenon may involve the related SOX factors, SOX7 and SOX17, given their role in early vascular development (11,13,16,31,39 -41) .
Vascular and lymphatic defects in hypotrichosis-lymphedema-telangiectasia syndrome SOX18 has an additional primary role in lymphatic vascular development (27) . Defects specific to lymphatic failure, such as chylous ascites, have been observed in both mouse and human mutants of SOX18 (14,18,20 -23) , so that vascular defects alone may not explain the edema seen in Ra Op embryos and HLT patients. Conversely, the edema in Ra Op mutants appeared at 12.5 dpc, prior to the formation of the first functional lymphatic vessels (13.5 dpc) and prior to the age of onset of lymphedema in mouse mutants of lymphatic differentiation factors, such as PROX1 and VEGFC (42, 43) . These observations suggest that edema in Ra Op and HLT is caused by a combination of high levels of fluid extravasation and impaired lymphatic vascular resorption.
Targets of SOX18 in vascular development
SOX18 has previously been shown to regulate two vascular endothelial target genes. One of these, Vcam1 (44) has no apparent role in vascular maturation: Vcam1-null embryos show no generalized edema or other features of Ra Op embryos (45, 46) . In addition, regulation of claudin-5 expression by SOX18 has recently been demonstrated in cultured endothelial cells (47) . However, null mouse analysis has indicated that claudin-5 is predominantly required for the integrity of the blood-brain barrier in late-stage embryonic development (48) . Claudin-5 does not appear to play a role in vascular integrity or development in other contexts (47) .
Our present studies identified three factors, Il7r, Mmp7 and N-cadherin, that are downregulated in Ra Op homozygotes. While some null animal models for N-cadherin have indicated its early requirement in embryonic vascular development, several studies have shown a pivotal role for this cell adhesion molecule in the association of pericytes with the endothelium of developing vessels (49 -54) . In particular, studies of the angiogenic behavior of cultured and in vivo endothelial cells null for N-cadherin expression have shown a decrease in the recruitment of pericytes to newly forming vessels but no impairment of the earlier stages of angiogenesis (53, 55, 56) . Given our present evidence for reduced pericyte recruitment to microvessels in the Ra Op homozygote and the presence of endothelial hyperplasia, a defect associated with impaired pericytic investment, the downregulation of N-cadherin may provide a molecular mechanism to explain this aspect of the SOX18 mutant phenotype (28) .
Similarly, it is possible that decreased levels of MMP7 contribute to the Ra Op phenotype. MMP7 is required for the regulation of adherens junction stability via degradation of VE-cadherin and regulation of VE-cadherin expression during vessel formation (57 -60) , although Mmp7 null mutant mice do not show Ra Op -like defects (61). However, any role for IL7R in regulating blood vessel maturation and integrity remains to be determined. Previous studies have indicated that endothelial IL7R is involved in the induction of lymphangiogenesis and upregulation of endothelial cell proliferation (62, 63) . Future studies will focus on characterizing the regulatory relationship of SOX18 to the putative target genes Il7r, Mmp7 and N-cadherin, and investigating the role these factors might play in the Ra Op and HLT phenotypes. Op homozygotes when compared with wild-type at 10.5 dpc by real-time quantitative RT -PCR analysis, but Il7r, Mmp7 and N-cadherin expression was significantly downregulated. Tie1, tyrosine kinase with immunoglobulin and epidermal growth factor homology domains-1; ZO-1, zonula occludens-1; Pdgfb, platelet-derived growth factor-B; Il7r, interleukin-7 receptor; Mmp7, matrix metalloprotease-7.
Ã P 0.05. Quantitative polymerase chain reaction analysis cDNA was amplified in triplicate in a reaction volume of 25 ml using SYBR Green Gene Expression Assay (Applied Biosystems) and an ABI/Prism 7000 HT thermocycler using a pre-PCR step of 10 min at 958C, followed by 40 cycles of 15 s at 958C and 60 s at 608C. Preparations of RNA template without reverse transcriptase were used as negative controls. C t values were normalized to 18S expression (64) .
MATERIALS AND METHODS
Animals and genotyping
Wholemount in situ hybridization
Samples were fixed overnight in 4% paraformaldehyde, and dehydrated in methanol. Whole embryos (n ¼ 4) were hybridized overnight with riboprobe for Flk-1 (26) labeled with digoxigenin (Roche, Castle Hill, Australia) according to the manufacturer's instructions. Embryos were then incubated with anti-digoxigenin antibody coupled to alkaline phosphatase (1:2500; Roche) until color reaction was seen.
Histology and electron microscopy
Embryos (n ¼ 26) for histological examination were fixed in 4% paraformaldehyde at 48C overnight and embedded in paraffin. Blocks were then sectioned (6 -10 mm) and stained with hematoxylin -eosin. For transmission electron microscopy, embryo tissue was rapidly fixed in 2.5% glutaraldehyde, embedded in epon and sectioned transversely.
Immunofluorescence
Cryosectioned embryos (10 mm, n ¼ 2) were pre-incubated with blocking solution [100 mM maleic acid pH 7.4, 10% horse serum in phosphate-buffered saline (PBS) containing 0.1% Triton X-100 (PBSTx)] at room temperature for 1 h, then with the primary antibody overnight at 48C. Secondary antibody was applied at room temperature for 1 h. Slides were mounted in PBS/60% glycerol. Antibodies were rat anti-PECAM-1 (BD-Pharmingen, Palo Alto, CA, USA) and mouse anti-NG2 proteoglycan (Chemicon, Boronia, Australia).
Intravascular dye injection
Embryos (n ¼ 11) with yolk sac and placenta intact were dissected and placed immediately into PBS at 48C for 5 -10 min. Small volumes (1 -5 ml) of 10% India ink were injected into the yolk sac vasculature and allowed to circulate via the umbilical vein. After 5 min at room temperature, injected embryos were returned to 48C for at least 10 min before analysis.
SUPPLEMENTARY MATERIAL
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